MedPath

Clinpro 5000

These highlights do not include all the information needed to use 3M ESPE Clinpro 5000 Anti-Cavity Toothpaste safely and effectively. See full prescribing information for Clinpro 5000 Anti-Cavity Toothpaste.3M ESPE Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste for oral use.Initial U.S. Approval: None

Approved
Approval ID

a20d3cf0-2e1f-4191-971e-9e47936b4580

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 1, 2024

Manufacturers
FDA

Solventum US OpCo LLC

DUNS: 801390852

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

sodium fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code48878-3130
Product Classification
G
Generic Name
sodium fluoride
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2024
FDA Product Classification

INGREDIENTS (11)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT
sodium fluorideActive
Quantity: 5 mg in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM
SorbitolInactive
Code: 506T60A25R
Classification: IACT
Carboxymethylcellulose SodiumInactive
Code: K679OBS311
Classification: IACT
Polyethylene Glycol, UnspecifiedInactive
Code: 3WJQ0SDW1A
Classification: IACT
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT
Tricalcium PhosphateInactive
Code: K4C08XP666
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT

sodium fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code48878-3140
Product Classification
G
Generic Name
sodium fluoride
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2024
FDA Product Classification

INGREDIENTS (11)

GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Polyethylene Glycol, UnspecifiedInactive
Code: 3WJQ0SDW1A
Classification: IACT
Tricalcium PhosphateInactive
Code: K4C08XP666
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
SorbitolInactive
Code: 506T60A25R
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
sodium fluorideActive
Quantity: 5 mg in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM
Carboxymethylcellulose SodiumInactive
Code: K679OBS311
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT

sodium fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code48878-3120
Product Classification
G
Generic Name
sodium fluoride
Product Specifications
Route of AdministrationORAL
Effective DateApril 1, 2024
FDA Product Classification

INGREDIENTS (11)

WaterInactive
Code: 059QF0KO0R
Classification: IACT
sodium fluorideActive
Quantity: 5 mg in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM
Sodium Lauryl SulfateInactive
Code: 368GB5141J
Classification: IACT
SorbitolInactive
Code: 506T60A25R
Classification: IACT
GlycerinInactive
Code: PDC6A3C0OX
Classification: IACT
Silicon DioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Tricalcium PhosphateInactive
Code: K4C08XP666
Classification: IACT
Saccharin SodiumInactive
Code: SB8ZUX40TY
Classification: IACT
Titanium DioxideInactive
Code: 15FIX9V2JP
Classification: IACT
Carboxymethylcellulose SodiumInactive
Code: K679OBS311
Classification: IACT
Polyethylene Glycol, UnspecifiedInactive
Code: 3WJQ0SDW1A
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/1/2024

Principal Display Panel – Box Label

3M ESPE

NDC 48878-3140-4

Clinpro™ 5000

Bubble Gum

1.1% Sodium Fluoride

Anti-Cavity Toothpaste

Innovative

Tri-Calcium

Phosphate

Exclusively from 3M ESPE

Contents: 1 Tube NET WT 4oz (113g)

Rx Only

Principal Display Panel – Box Label

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 9/15/2008

1 INDICATIONS AND USAGE

Clinpro 5000 Anti-Cavity Toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries.

Key Highlight

Clinpro 5000 Anti-Cavity Toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. (1)

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 9/15/2008

4 CONTRAINDICATIONS

Do not use in children under 6 years of age unless recommended by a dentist or physician.

Key Highlight

Do not use in children under 6 years of age unless recommended by a dentist or physician. (4)

WARNINGS AND PRECAUTIONS SECTION

LOINC: 43685-7Updated: 9/15/2008

5 WARNINGS AND PRECAUTIONS

• DO NOT SWALLOW. If more than a pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste is swallowed, contact a medical or dental professional or a poison control center.

• Keep out of reach of children under 6 years of age.

• Repeated ingestion of high levels of fluoride may cause dental fluorosis. For this reason, use in children with developing dentition requires special supervision to prevent swallowing. Prescribing dentists and physicians should consider risk of fluorosis when prescribing for use in children less than 6 years of age.

Key Highlight
  • Do not swallow. (5)
  • Keep out of reach of children under 6 years of age. (5)
  • Repeated ingestion of high levels of fluoride may cause dental fluorosis. (5)

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 9/15/2008

6 ADVERSE REACTIONS

Allergic reactions and other idiosyncrasies have been rarely reported.

Key Highlight

Allergic reactions and other idiosyncrasies have been rarely reported. (6)

To report SUSPECTED ADVERSE REACTIONS, contact 3M ESPE Dental Products Division at 1-800-634-2249 orwww.3MESPE.com, or FDA at 1-800-FDA-1088 or****www.fda.gov/medwatch

DOSAGE FORMS & STRENGTHS SECTION

LOINC: 43678-2Updated: 9/15/2008

3 DOSAGE FORMS AND STRENGTHS

White toothpaste containing 1.1% sodium fluoride

Key Highlight

White toothpaste containing 1.1% sodium fluoride (3)

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/11/2012

2 DOSAGE AND ADMINISTRATION

• Use once daily in place of conventional toothpaste unless instructed otherwise by a physician or dentist.

• Apply a thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste using a soft-bristled toothbrush and brush teeth for at least two minutes.

• After brushing adults should expectorate. Children 6 to 16 years of age should expectorate and rinse mouth thoroughly with water.

• Follow these instructions or use as directed by a dental professional.

Key Highlight
  • Use once daily in place of conventional toothpaste unless instructed otherwise by a physician or dentist. (2)
  • Apply a thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste using a soft-bristled toothbrush and brush teeth for at least two minutes. (2)
  • After brushing adults should expectorate. Children 6 to 16 years of age should expectorate and rinse mouth thoroughly with water. (2)

OVERDOSAGE SECTION

LOINC: 34088-5Updated: 9/15/2008

10 OVERDOSAGE

Ingestion of large amounts of fluoride may result in abdominal pain, stomach upset, nausea, vomiting, and diarrhea. These symptoms may occur at overdosages of 5 mg/kg of body weight. Fluoride doses of 16 mg/kg have been fatal.

Treatment Recommendations for Overdose of Clinpro 5000 Anti-Cavity Toothpaste4

Ingested fluoride dose

Amount for 10 kg (22 pound) child*

Recommended action to take

Less than 5 mg/kg

This equals less than ½ ounce (or less than 3 teaspoons).

Do not induce vomiting. Give 1-2 glasses of milk and observe for symptoms of stomach upset. If symptoms persist more than a few hours, seek medical attention or contact a poison control center.

5 mg/kg or more

This equals about ½ ounce (about 1 tablespoon) or more.

Do not induce vomiting. Give 1-2 glasses of milk and seek medical attention or contact a poison control center.

15 mg/kg

This equals 1 ounce or ¼ of the tube.

Seek immediate medical attention. Do not induce vomiting. Give 1-2 glasses of milk.

*The amount to reach the fluoride dose will be proportionately larger with older children and adults.

A thin ribbon or pea-sized amount of Clinpro 5000 Anti-Cavity Toothpaste weighs approximately 0.3 g and contains approximately 1.5 mg of fluoride ion. A 4 oz. tube contains 564 mg of fluoride ion.

DESCRIPTION SECTION

LOINC: 34089-3Updated: 9/15/2008

11 DESCRIPTION

Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste is a self-applied fluoride dentifrice for the prevention of dental caries. Each gram contains 5 mg of fluoride ion in a neutral pH base, consisting of water, sorbitol, hydrated silica, glycerin, polyethylene-polypropylene glycol, flavor, polyethylene glycol, sodium lauryl sulfate, titanium dioxide, carboxymethyl cellulose, sodium saccharin and tri-calcium phosphate.

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 9/15/2008

12 CLINICAL PHARMACOLOGY

Clinpro 5000 1.1% Sodium Fluoride Anti-Cavity Toothpaste aids in the prevention of tooth decay. Fluoride delivered from Clinpro 5000 inhibits the demineralization of sound teeth and enhances the remineralization (i.e., repair) of demineralized teeth. During tooth brushing, fluoride is taken up by teeth and dental plaque. Fluoride is taken up with calcium and phosphate by demineralized teeth resulting in an improved tooth structure than contains more fluoride and less carbonate than naturally occurring tooth structure and is more resistant to acid challenge. Additionally, calcium fluoride is formed on the crystal structure of teeth. As the pH of the mouth drops, fluoride is released from calcium fluoride and aids in the remineralization of teeth. Fluoride taken up into plaque alters the activity of cariogenic bacteria. Fluoride inhibits the process by which cariogenic bacteria metabolize carbohydrates resulting in less acid and adhesive polysaccharide production by the bacteria.

REFERENCES SECTION

LOINC: 34093-5Updated: 9/15/2008

15 REFERENCES

  1. National Research Council. Fluoride in drinking water: A scientific review of EPA's standards; National Academies Press 2006.
  2. IOM. Dietary Reference Intakes: The essential guide to nutrient requirements. National Academies Press 2006.
  3. Heindel JJ, et al. Developmental toxicity evaluation of sodium fluoride administered to rats and rabbits in drinking water. Fundam Appl Toxicol 1996;30(2):162-177.
  4. Poisindex. Toxicologic Management – Fluoride. Thomson Micromedex.

USE IN SPECIFIC POPULATIONS SECTION

LOINC: 43684-0Updated: 9/15/2008

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Fluoride crosses the placenta in women and has been measured in cord blood, amniotic fluid, and serum of newborn children, but without a consistent correlation to maternal serum fluoride levels.1,2 There are no data to indicate an increased susceptibility to fluorosis during pregnancy. Developmental studies were conducted by the National Toxicology Program, with sodium fluoride administered in the drinking water to pregnant rats and rabbits. No developmental toxicity was observed, even at doses that caused maternal toxicity. The No Adverse Effect Levels were about 29 mg/kg-day and 27 mg/kg-day for rabbits and rats, respectively.3 There is no conclusive evidence of fluoride developmental effects in humans.1,2

The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for pregnant women.2

Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in pregnant women or women who may become pregnant.

8.3 Nursing Mothers

An extremely small proportion of fluoride in drinking water is transferred to breast milk. The Institute of Medicine established a fluoride Upper Limit of 10 mg/day for nursing women.2 Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in women who are nursing.

8.4 Pediatric Use

The primary adverse effects of fluoride are fluorosis of dental enamel and of the skeleton; these effects occur at exposures below those associated with other adverse health effects. The population most at risk for dental fluorosis is children during the period of tooth formation, i.e. from birth to 8 years of age. For this population, the Institute of Medicine established Fluoride Upper Limits of intake based on the risk of dental fluorosis. In populations with permanent dentition, skeletal fluorosis is the greatest risk from excessive fluoride. For this population the Institute of Medicine (IOM) established Fluoride Upper Limits based on the risk of skeletal fluorosis.2

Population

IOM Fluoride Upper Limit

Infants 0-6 months old

0.7 mg/day

Infants 7-12 months old

0.9 mg/day

Children 1-3 years old

1.3 mg/day

Children 4-8 years old

2.2 mg/day

Children > 8 years old

10 mg/day

Prescribing physicians and dentists should consider total fluoride exposure (dental care plus food, water and other sources) when prescribing the product for use in children.

8.5 Geriatric Use

No studies of Clinpro 5000 Anti-Cavity Toothpaste have been conducted to determine whether subjects aged 65 and over respond differently from younger subjects.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 1/11/2012

16 HOW SUPPLIED/STORAGE AND HANDLING

Clinpro 5000 Anti-Cavity Toothpaste is supplied as a white dentifrice paste in a 4 oz. (113 gm) plastic tube (NDC 48878-3120-4, Vanilla Mint Flavor; NDC 48878-3130-4 Spearmint Flavor; NDC 48878-3140-4 Bubble Gum Flavor).

Storage

This product is designed to be stored and used at room temperature. Do not freeze or expose to extreme heat. See outer package for expiration date.

Manufactured for:
3M ESPE
****Dental Products
2510 Conway Avenue
St. Paul, MN 55144-1000 USA
Revision date: 01/11/2012

Rx Only

3M, ESPE, and Clinpro are trademarks of 3M or 3M Deutschland GmbH.
© 3M 2016. All rights reserved.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Clinpro 5000 - FDA Drug Approval Details